Washington, February 9: Johnson and Johnson (JNJ) has finally got a green signal from The Food and Drug Administration (FDA), to market a device that could be a potential cure for the common heart-rhythm disorder called atrial fibrillation. This is the first ever approval given by the FDA for a device of this kind.
The Food and Drug Administration (FDA) has approved the first of its kind drug made from the Genetically Engineered (GE) livestock. The drug called ATryn has been manufactured by GTC Biotherapeutics Inc.
Disclaimer: The views and investment tips expressed by investment experts on themoneytimes.com are their own, and not that of the website or its management. TheMoneyTimes advises users to check with certified experts before taking any investment decision.